KARA LOMSKI: Open Payments
NPI 1609583962 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 17 payments from 11 companies in 2025. Trend: 2023 $663 · 2024 $688 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| ABBVIE INC. | 3 | $61 |
| Amgen Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| MERZ NORTH AMERICA, INC. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $17 |
Products named: Ozempic, EVENITY, QULIPTA, BREZTRI, Veozah, Rybelsus, GARDASIL 9, Korlym.
Industry payments across FL — which companies pay providers there.
